NCT05931263View on ClinicalTrials.gov

A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL

PHASE3RecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 29, 2028

Conditions
Newly Diagnosed Peripheral T-cell Lymphoma
Interventions
DRUG

C-BEAM Regimen

Chidemide，carmustine, etoposide, cytarabine, and melphalan

DRUG

BEAM Regimen

carmustine, etoposide, cytarabine, and melphalan

Trial Locations (1)

210029

RECRUITING

Hematological Department, People's Hospital of Jiangsu Province, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER